Biostar Pharmaceuticals, Inc.
BSPM
BSPM was delisted on the 18th of September, 2018.
6 hedge funds and large institutions have $203K invested in Biostar Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
25% less funds holding
Funds holding: 8 → 6 (-2)
37% less capital invested
Capital invested by funds: $324K → $203K (-$121K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$8.64K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.13K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.7K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$21K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$8K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$6K |
| 4 |
ISB
Iowa State Bank
Urbandale,
Iowa
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $200K | +$8.64K | +3,803 | +4% |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$2.13K | +937 | +5,512% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | +$1.7K | +749 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| – | -$21K | -7,412 | Closed |
|
|
VKH
5
Virtu KCG Holdings
New York
| – | -$8K | -2,707 | Closed |
|
|
6
California Public Employees Retirement System
Sacramento,
California
| – | -$6K | -2,017 | Closed |
|
|
ISB
7
Iowa State Bank
Urbandale,
Iowa
| – | -$5K | -1,769 | Closed |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$2 | +1 | New |
|
BSPM Hedge Fund Activity: Q1 2016 in Review
6 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q1 2016, worth a combined $203K — down 37% from $324K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BSPM and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $8.64K. The largest seller was Citadel Advisors, exiting entirely with an estimated $21K sold.
- 6 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q1 2016, down from 8 in Q4 2015.
- Funds reported $203K of Biostar Pharmaceuticals, Inc. stock for Q1 2016, down 37% quarter-over-quarter.
- 2 funds opened new Biostar Pharmaceuticals, Inc. positions in Q1 2016 and 4 closed out, a net change of -2 holders.
- The largest Biostar Pharmaceuticals, Inc. buyer in Q1 2016 was Renaissance Technologies, an estimated $8.64K added.
- The largest Biostar Pharmaceuticals, Inc. seller in Q1 2016 was Citadel Advisors, an estimated $21K sold.
Based on aggregated 13F filings for Q1 2016.